Bhatia, Sangeeta N. http://orcid.org/0000-0002-1293-2097
Chen, Xiaoyuan http://orcid.org/0000-0002-9622-0870
Dobrovolskaia, Marina A. http://orcid.org/0000-0002-4233-9227
Lammers, Twan http://orcid.org/0000-0002-1090-6805
Article History
Accepted: 27 June 2022
First Online: 8 August 2022
Competing interests
: S.N.B. reports compensation for cofounding, consulting, and/or board membership in Glympse Bio, Satellite Bio, CEND Therapeutics, Xilio Therapeutics, Catalio Capital, Intergalactic Therapeutics, Port Therapeutics, Vertex Pharmaceuticals, Danaher and Moderna, and receives sponsored research funding from Johnson & Johnson, Revitope and Owlstone Medical. X.C. is a co-founder of Shanghai Lannacheng Biotech Co., Ltd (China), Editor-in-Chief of Theranostics (Ivyspring, Australia), President of Theranostics Consulting LLC (USA) and a consultant for Molecular Targeting Technologies, Inc. (USA) and Yantai Dongcheng Pharmaceutical Group (China). M.A.D. and T.L. declare no competing interests.
Free to read: This content has been made available to all.